{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:31:32Z","timestamp":1791498692291,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pneumonia remains a major cause of morbidity and mortality worldwide. Rapid diagnostic testing with molecular syndromic panels (MSP) has proved useful for the management of antimicrobial treatment of hospital-acquired pneumonia (HAP). In this study, we evaluated the impact of early use of MSP testing in the Emergency Department (ED) for the management of antibiotic therapy in patients with moderate to severe CAP with risk factors for multi-drug-resistant pathogens (CAP-MDR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>\n                      Patients presenting at the ED with diagnosis of moderate to severe CAP-MDR underwent microbiological analysis of lower respiratory tract specimens by culture and MSP testing (bioM\u00e9rieux, FilmArray\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Pneumonia Plus Panel). The primary outcome was the percentage of cases in which MSP testing modified the empiric antimicrobial therapy started according to local protocols. Among the secondary outcomes we included the time elapsed from ED admission to antibiotic change or confirmation upon receipt of the MSP results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between June 2024 and May 2025, 93 patients were enrolled (age, 72.9\u2009\u00b1\u200913.9 years; 62.4% males). MSP testing identified one or more pathogens in 91.4% of cases. Modification of empiric antibiotic therapy, started according to local protocols, occurred in 65.6% of patients (escalation in 44.1% and de-escalation in 21.5% of cases) after 11.4\u2009\u00b1\u20096.3\u00a0h (IQR 12.0) since ED presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The early use of MSP on lower respiratory samples collected in the ED from patients with diagnosis of moderate to severe CAP-MDR could allow a rapid and targeted modification of the empiric antibiotic therapy in these patients, with potential advantages on antimicrobial stewardship and patient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-025-05376-2","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:56:06Z","timestamp":1765367766000},"page":"863-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rapid testing with molecular syndromic panels of patients presenting at the emergency department with pneumonia at risk for multidrug-resistant pathogens"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1849-8372","authenticated-orcid":false,"given":"Lorenzo","family":"Pelagatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Muz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-4935","authenticated-orcid":false,"given":"Lorenzo","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-6539","authenticated-orcid":false,"given":"Sara","family":"Tomassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7877-0462","authenticated-orcid":false,"given":"Alberto","family":"Farese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-1523","authenticated-orcid":false,"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Caldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7037-9546","authenticated-orcid":false,"given":"Mattia","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-058X","authenticated-orcid":false,"given":"Tommaso","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-9148","authenticated-orcid":false,"given":"Peiman","family":"Nazerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9386-0434","authenticated-orcid":false,"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-5715","authenticated-orcid":false,"given":"Simone","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"5376_CR1","doi-asserted-by":"crossref","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H et al (2020) International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases Monard Critical Care 24:434 Page 10 of 11 (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT). Eur Respir J. 2017;50:1700582","DOI":"10.1183\/13993003.00582-2017"},{"issue":"11","key":"5376_CR2","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cid\/cix647","volume":"65","author":"Y Ramirez","year":"2017","unstructured":"Ramirez Y, Wiemken JA, Peyrani TL (2017) Adults hospitalized with pneumonia in the united states: incidence, epidemiology, and mortality. Clin Infect Dis 65(11):1806\u20131812","journal-title":"Clin Infect Dis"},{"key":"5376_CR3","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia. Am J Respir Crit Care Med 171: 388, 2005. [PMID: 15699079]","DOI":"10.1164\/rccm.200405-644ST"},{"key":"5376_CR4","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","volume":"128","author":"MH Kollef","year":"2005","unstructured":"Kollef MH, Shorr A, Taback YP et al (2005) Epidemiology and outcomes of healthcare-associated pneumonia; results from a large US database of culture-positive pneumonia. Chest 128:3854 [PMID: 16354854]","journal-title":"Chest"},{"key":"5376_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/archinte.159.9.970","volume":"159","author":"MJ Fine","year":"1999","unstructured":"Fine MJ, Stone RA, Singer DE et al (1999) Processes and outcomes of care for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team (PORT) cohort study. Arch Intern Med 159:970 [PMID: 10326939]","journal-title":"Arch Intern Med"},{"issue":"1","key":"5376_CR6","doi-asserted-by":"publisher","first-page":"e0191721","DOI":"10.1371\/journal.pone.0191721","volume":"13","author":"M Ferrer","year":"2018","unstructured":"Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani OT, Polverino E, Liapikou A, Blasi F, Torres A (2018) Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS One 13(1):e0191721. https:\/\/doi.org\/10.1371\/journal.pone.0191721. (PMID: 29370285; PMCID: PMC5784994)","journal-title":"PLoS One"},{"key":"5376_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","volume":"27","author":"MJ Richards","year":"1999","unstructured":"Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infec-tions in medical ICUs in the united states: National nosocomialinfections surveillance system. Crit Care Med 27:887\u2013892","journal-title":"Crit Care Med"},{"key":"5376_CR8","doi-asserted-by":"publisher","first-page":"N64","DOI":"10.1097\/00003246-200104001-00002","volume":"29","author":"SK Fridkin","year":"2001","unstructured":"Fridkin SK (2001) Increasing prevalence of antimicrobial resistance in inten-sive care units. Crit Care Med 29:N64\u2013N68","journal-title":"Crit Care Med"},{"issue":"5","key":"5376_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.chest.2017.04.162","volume":"152","author":"RE Corrado","year":"2017","unstructured":"Corrado RE, Lee D, Lucero DE, Varma JK, Vora NM (2017) Burden of adult community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia: new York City, 2010 to 2014. Chest 152(5):930\u2013942. https:\/\/doi.org\/10.1016\/j.chest.2017.04.162","journal-title":"Chest"},{"issue":"6","key":"5376_CR10","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","volume":"128","author":"MH Kollef","year":"2005","unstructured":"Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128(6):3854\u20133862. https:\/\/doi.org\/10.1378\/chest.128.6.3854","journal-title":"Chest"},{"issue":"7","key":"5376_CR11","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med 200(7):e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"5376_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00735-2022","volume":"61","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, Bos L, Chalmers JD, Derde L, de Waele J, Garnacho-Montero J, Kollef M, Luna C, Menendez R, Niederman M, Ponomarev D, Restrepo M, Rigau D, Schultz MJ, Weiss E, Welte T, Wunderink R (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J 61(4):2200735. https:\/\/doi.org\/10.1183\/13993003.00735-2022","journal-title":"Eur Respir J"},{"key":"5376_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2016.08.004","volume":"36","author":"RT Attridge","year":"2016","unstructured":"Attridge RT, Frei CR, Pugh MJ, Lawson KA, Ryan L, Anzueto A, Metersky ML, Restrepo MI, Mortensen EM (2016) Health care-associated pneumonia in the intensive care unit: guideline-concordant antibiotics and outcomes. J Crit Care 36:265\u2013271. https:\/\/doi.org\/10.1016\/j.jcrc.2016.08.004","journal-title":"J Crit Care"},{"issue":"3","key":"5376_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cid\/cit734","volume":"58","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Rother C, Salih W, Ewig S (2014) Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 58(3):330\u2013339. https:\/\/doi.org\/10.1093\/cid\/cit734","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5376_CR15","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1128\/JCM.00325-14","volume":"52","author":"W Jamal","year":"2014","unstructured":"Jamal W, Al Roomi E, AbdulAziz LR, Rotimi VO (2014) Evaluation of curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia. J Clin Microbiol 52(7):2487\u20132492. https:\/\/doi.org\/10.1128\/JCM.00325-14Epub 2014 Apr 30. PMID: 24789196; PMCID: PMC4097734","journal-title":"J Clin Microbiol"},{"issue":"10","key":"5376_CR16","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s10096-021-04259-6","volume":"40","author":"L Sun","year":"2021","unstructured":"Sun L, Li L, Du S, Liu Y, Cao B (2021) An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. Eur J Clin Microbiol Infect Dis 40(10):2113\u20132121. https:\/\/doi.org\/10.1007\/s10096-021-04259-6Epub 2021 May 1. PMID: 33934275","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"5376_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jmii.2019.10.009","volume":"52","author":"SH Lee","year":"2019","unstructured":"Lee SH, Ruan SY, Pan SC, Lee TF, Chien JY, Hsueh PR (2019) Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. J Microbiol Immunol Infect 52(6):920\u2013928. https:\/\/doi.org\/10.1016\/j.jmii.2019.10.009","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"5376_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03114-y","volume":"24","author":"C Monard","year":"2020","unstructured":"Monard C, Pehlivan J, Auger G, Alviset S, Tran Dinh A, Duquaire P, Gastli N, d\u2019Humi\u00e8res C, Maamar A, Boibieux A, Baldeyrou M, Loubinoux J, Dauwalder O, Cattoir V, Armand-Lef\u00e8vre L, Kern\u00e9is S, ADAPT study group (2020) Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Crit Care 24(1):434. https:\/\/doi.org\/10.1186\/s13054-020-03114-y","journal-title":"Crit Care"},{"issue":"1","key":"5376_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s13063-021-05618-6","volume":"22","author":"J High","year":"2021","unstructured":"High J, Enne VI, Barber JA, Brealey D, Turner DA, Horne R, Peters M, Dhesi Z, Wagner AP, Pandolfo AM, Stirling S, Russell C, O\u2019Grady J, Swart AM, Gant V, Livermore DM, INHALE Study Group (2021) Inhale: the impact of using filmarray pneumonia panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK critical care-study protocol for a multicentre randomised controlled trial. Trials 22(1):680. https:\/\/doi.org\/10.1186\/s13063-021-05618-6. (PMID: 34620213; PMCID: PMC8496625)","journal-title":"Trials"},{"issue":"1","key":"5376_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s13063-022-06467-7","volume":"23","author":"S Serigstad","year":"2022","unstructured":"Serigstad S, Ritz C, Faurholt-Jepsen D, Markussen D, Ebbesen MH, Kommedal \u00d8, Bj\u00f8rneklett RO, Heggelund L, Clark TW, van Werkhoven CH, Knoop ST, Ulvestad E, Grewal HMS, CAPNOR study group (2022) Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR). Trials 23(1):622. https:\/\/doi.org\/10.1186\/s13063-022-06467-7. (PMID: 35915452; PMCID: PMC9340738)","journal-title":"Trials"},{"issue":"12","key":"5376_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123134","volume":"12","author":"D Escudero","year":"2022","unstructured":"Escudero D, Fern\u00e1ndez-Suarez J, Forcelledo L, Balboa S, Fern\u00e1ndez J, Astola I, Quindos B, Campos R, V\u00e1zquez F, Boga JA (2022) Evaluation and clinical impact of Biofire FilmArray Pneumonia Panel Plus in ICU-hospitalized COVID-19 patients. Diagnostics (Basel) 12(12):3134. https:\/\/doi.org\/10.3390\/diagnostics12123134","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"5376_CR22","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10096-019-03526-x","volume":"38","author":"NJ Gadsby","year":"2019","unstructured":"Gadsby NJ, McHugh MP, Forbes C, MacKenzie L, Hamilton SKD, Griffith DM, Templeton KE (2019) Comparison of Unyvero P55 pneumonia cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting. Eur J Clin Microbiol Infect Dis 38(6):1171\u20131178. https:\/\/doi.org\/10.1007\/s10096-019-03526-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"5376_CR23","doi-asserted-by":"publisher","first-page":"e02497","DOI":"10.1128\/JCM.02497-20","volume":"59","author":"M Klein","year":"2021","unstructured":"Klein M et al (2021) Multicenter evaluation of the Unyvero platform for testing bronchoalveolar lavage fluid. J Clin Microbiol 59(3):e02497\u2013e02420","journal-title":"J Clin Microbiol"},{"issue":"7","key":"5376_CR24","doi-asserted-by":"publisher","first-page":"e00128","DOI":"10.1128\/JCM.00128-20","volume":"58","author":"CN Murphy","year":"2020","unstructured":"Murphy CN et al (2020) Multicenter evaluation of the biofire filmarray pneumonia\/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol 58(7):e00128\u2013e00120","journal-title":"J Clin Microbiol"},{"issue":"2","key":"5376_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00134-024-07772-2","volume":"51","author":"VI Enne","year":"2025","unstructured":"Enne VI, Stirling S, Barber JA et al (2025) Inhale WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia. Intensive Care Med 51(2):272\u2013286. https:\/\/doi.org\/10.1007\/s00134-024-07772-2","journal-title":"Intensive Care Med"},{"issue":"6","key":"5376_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jinf.2022.09.003","volume":"85","author":"S Poole","year":"2022","unstructured":"Poole S, Tanner AR, Naidu VV et al (2022) Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: results of a randomised controlled trial. J Infect 85(6):625\u2013633. https:\/\/doi.org\/10.1016\/j.jinf.2022.09.003","journal-title":"J Infect"},{"issue":"9","key":"5376_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S2213-2600(22)00086-8","volume":"10","author":"AM Darie","year":"2022","unstructured":"Darie AM, Khanna N, Jahn K et al (2022) Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 10(9):877\u2013887. https:\/\/doi.org\/10.1016\/S2213-2600(22)00086-8","journal-title":"Lancet Respir Med"},{"issue":"5","key":"5376_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.str.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604\u2013607. https:\/\/doi.org\/10.1161\/01.str.19.5.604","journal-title":"Stroke"},{"key":"5376_CR29","unstructured":"[Agenzia Regionale di Sanit\u00e0 della Toscana (ARS Toscana). L\u2019antibiotico-resistenza e l\u2019uso di antibiotici in Toscana. Rapporto 2023. Firenze: ARS Toscana (2024) Available from: https:\/\/www.ars.toscana.it\/images\/pubblicazioni\/Collana_ARS\/2024\/Documento_ATB-resistenza_2023xweb.pdf]. It represents a report from Tuscany region"},{"issue":"1","key":"5376_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14737159.2022.2018302","volume":"22","author":"E Riccobono","year":"2022","unstructured":"Riccobono E, Bussini L, Giannella M, Viale P, Rossolini GM (2022) Rapid diagnostic tests in the management of pneumonia. Expert Rev Mol Diagn 22(1):49\u201360. https:\/\/doi.org\/10.1080\/14737159.2022.2018302","journal-title":"Expert Rev Mol Diagn"},{"key":"5376_CR31","doi-asserted-by":"publisher","unstructured":"Markussen DL, Kommedal \u00d8, Knoop ST et al (2024) Microbial aetiology of community-acquired pneumonia in hospitalised adults: A prospective study utilising comprehensive molecular testing [published correction appears in int J infect Dis. 2024;146:107126. Doi: 10.1016\/j.ijid.2024.107126]. Int J Infect Dis 143:107019. https:\/\/doi.org\/10.1016\/j.ijid.2024.107019","DOI":"10.1016\/j.ijid.2024.107019"},{"issue":"1","key":"5376_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13054-020-03067-2","volume":"24","author":"N Peiffer-Smadja","year":"2020","unstructured":"Peiffer-Smadja N, Bouadma L, Mathy V et al (2020) Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia. Crit Care 24(1):366. https:\/\/doi.org\/10.1186\/s13054-020-03067-2. Published 2020 Jun 19","journal-title":"Crit Care"},{"key":"5376_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-023-03461-3","author":"P Garrido","year":"2023","unstructured":"Garrido P, Gabald\u00f3-Barrios X, Pujol-Bajador I et al (2023) Assessing the utility of multiplexed polymerase chain reaction in detecting microorganisms causing infections in critically ill patients. Curr Microbiol. https:\/\/doi.org\/10.1007\/s00284-023-03461-3","journal-title":"Curr Microbiol"},{"key":"5376_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00135-20","author":"BW Buchan","year":"2020","unstructured":"Buchan BW, Windham S, Balada-Llasat JM et al (2020) Practical comparison of the BioFire FilmArray pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.00135-20","journal-title":"J Clin Microbiol"},{"key":"5376_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad382","author":"MM Miller","year":"2023","unstructured":"Miller MM, Van Schooneveld TC, Stohs EJ et al (2023) Implementation of a rapid multiplex polymerase chain reaction pneumonia panel and subsequent antibiotic de-escalation. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofad382","journal-title":"Open Forum Infect Dis"},{"key":"5376_CR36","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.358","author":"JN Esplund","year":"2023","unstructured":"Esplund JN, Taylor AD, Stone TJ et al (2023) Clinical impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients. Antimicrob Steward Healthc Epidemiol. https:\/\/doi.org\/10.1017\/ash.2022.358","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"5376_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13010095","author":"J Dessajan","year":"2024","unstructured":"Dessajan J, Timsit JF (2024) Impact of multiplex PCR in the therapeutic management of severe bacterial pneumonia. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics13010095","journal-title":"Antibiotics"},{"issue":"6","key":"5376_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2023.101300","volume":"42","author":"AC Moy","year":"2023","unstructured":"Moy AC, Kimmoun A, Merkling T et al (2023) Performance evaluation of a PCR panel (FilmArray\u00ae Pneumonia Plus) for detection of respiratory bacterial pathogens in respiratory specimens: a systematic review and meta-analysis. Anaesthesia Critical Care & Pain Medicine 42(6):101300. https:\/\/doi.org\/10.1016\/j.accpm.2023.101300","journal-title":"Anaesthesia Critical Care & Pain Medicine"},{"key":"5376_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijid.2021.01.004","volume":"104","author":"IM Zacharioudakis","year":"2021","unstructured":"Zacharioudakis IM, Zervou FN, Dubrovskaya Y, Inglima K, See B, Aguero-Rosenfeld M (2021) Evaluation of a multiplex PCR panel for the Microbiological diagnosis of pneumonia in hospitalized patients: experience from an academic medical center. Int J Infect Dis 104:354\u2013360. https:\/\/doi.org\/10.1016\/j.ijid.2021.01.004","journal-title":"Int J Infect Dis"},{"issue":"9","key":"5376_CR40","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.cmi.2020.11.014","volume":"27","author":"N Gastli","year":"2021","unstructured":"Gastli N, Loubinoux J, Daragon M et al (2021) Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia. Clin Microbiol Infect 27(9):1308\u20131314. https:\/\/doi.org\/10.1016\/j.cmi.2020.11.014","journal-title":"Clin Microbiol Infect"},{"key":"5376_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-021-04213-6","author":"N Maataoui","year":"2021","unstructured":"Maataoui N, Chemali L, Patrier J et al (2021) Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/s10096-021-04213-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"5376_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00134-024-07402-x","volume":"50","author":"L Kreitmann","year":"2024","unstructured":"Kreitmann L, Nseir S (2024) Rapid syndromic multiplex PCR panels for the management of ventilator-associated lower respiratory tract infections: pondering important limitations. Author\u2019s reply. Intensive Care Med 50(5):787\u2013788. https:\/\/doi.org\/10.1007\/s00134-024-07402-x","journal-title":"Intensive Care Med"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05376-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:39:51Z","timestamp":1773495591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05376-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5376"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05376-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (CEAVC 26198_oss) was approved by the Tuscany Regional Ethics Committee (ClinicalTrials.gov: NCT06506617).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study approval statement"}},{"value":"Written informed consent was obtained from participants to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\u00a0statement"}},{"value":"The authors have no conflicts of interest to declare in relation to this study.Outside this study, GMR reports grants or contracts to the laboratory from Ada, Alifax, Arrow Diagnostics, Biomedical Service, bioM\u00e9rieux, Cepheid, Menarini, MSD, Qlinea, Qvella, SD Biosensor, Seegene, Shionogi; consulting fees from Advanz Pharma, bioM\u00e9rieux, Deepull, MSD, Viatris; honoraria for lectures, presentations, manuscript writing or educational events by bioM\u00e9rieux, Menarini, MSD, Pfizer, Shionogi, Relab.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflicts of interest"}}]}}